The immune response during treatment with belatacept after kidney transplantation.

Registry ID

EUCTR2012-003169-16

Source registry

EUCTR

Status

Ongoing

Phase

PHASE4

Sponsor

Erasmus MC, University Medical Center Rotterdam

Start date

2012-08-23

Last update

2026-08-16

Conditions

• Kidney transplantation

Summary

To characterize the function and phenotype of peripheral T-cells that determine rejection and graft acceptance during belatacept therapy after kidney transplantation.

Locations

• , , Netherlands

Related clinical trials

• Screening for subclinical antibody mediated rejection and efficacy of belatacept in the context of de novo donor specific antibody after kidney transplantation / BEL-AMR

View on source registry